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drugs to EU member states, identified in 2012 as many 
as thirty new synthetic cannabinoid receptor agonists 
on the market, i.e. 41% of the total number of newly 
reported drugs (EMCDDA, 2013). The appearance of new 
substances on the market is related to the current local 
laws. Authors who have investigated the phenomenon of 
synthetic cannabinoids agree that, if a substance is put 
under control, new ones not recognized by law will appear 
on the market (Dargan et al. 2011; Fattore & Fratta 2011; 
Hudson & Ramsey 2011) and continuous surveillance of 
the drug market is necessary. 
There are certain problems regarding analysis of 
synthetic cannabinoids that analytical laboratories are 
facing: often very low and variable concentration of synthetic 
cannabinoids products (Zuba et al. 2011, Choi et al., 2013), the 
presence of masking substances (tocopherol, esters of fatty 
acids, oleamide), scents, aromas and natural components 
from the plants used as carriers in products are the problems 
related to the clandestine manufacturing process of the 
products containing them. The dynamicity of the drug 
market creates a problem that many forensic laboratories are 
facing: the lack of reference materials.
As new products appear regularly on the market, the 
industry cannot keep pace with clandestine laboratories 
regarding analytical tests and reference material for new 
substances: often laboratory standards are not easily 
available, or they are expensive (Denooz et al. 2013; 
Vardakou et al. 2010; Zuba et al. 2011); furthermore, many 
substances have structural isomers which makes analysis 
even more demanding, since the standards of possible 
isomers should be analysed before a definitive conclusion 
about a specific isomer can be made. As long as some 
of these substances are legal, they probably will not be 
routinely analysed so manufacturers will not have interest 
in producing standards, which may also increase the price 
of available ones.
The isolation of the active principle from the 
analysed product has been used to obtain the pure 
substance, that can be subjected to NMR spectroscopy 
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Abstract: A total of six products containing legal highs 
were purchased via the internet from the UK- based 
retailers and screened for the presence of synthetic 
cannabinoids using a fast GC-MS method and identified, 
in the absence of reference materials, by comparing the 
mass spectra with the Scientific Working Group for the 
Analysis of Seized Drugs (SWGDRUG) mass spectral 
library. Four synthetic cannabinoids were detected: RCS-4, 
CP-47, 497, UR-144 and AM-2201. The active ingredient 
(1-(5-fluoropentyl)-3-(1-naphthoyl) indole), with the street 
name AM-2201, detected in the product named Doob was 
isolated and purified from the methanolic extract of the 
product using preparative HPLC with analytical column 
(column overloading method). The structure of the 
substance was confirmed using NMR. This approach used 
common analytical equipment found in forensic and other 
analytical laboratories (except for the NMR), therefore can 
be useful for the identification of unknown psychoactive 
substances in drugs of abuse.
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1  Introduction
Synthetic cannabinoid receptor agonists, also known as 
synthetic cannabinoids, are a class of novel psychoactive 
substances (NPS), found in herbal and incense products. 
In the few years since their first use as novel psychoactive 
substances the number of chemically different synthetic 
cannabinoids on the market exceeds 100. The EU Early 
warning system, which provides information about new 
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for definitive proof of the structure (Denooz et al. 2013; 
Ernst et al. 2011; Ernst et al. 2012; Moosmann et al. 2012; 
Jankovics et al. 2012). The isolation was done using silica 
gel column chromatography (Ernst et al., 2012; Ernst 
et al., 2011), flash chromatography (Moosmann et al., 
2012) and open column chromatography (Choi et al., 
2012). With the increase in number of new substances 
appearing on the market, there is a demand for  easily 
available reference material that can be obtained by 
isolation from the product. To use the commonly found 
analytical equipment for the isolation would be an 
advantage, since most forensic laboratories could isolate 
the active principle within a few days.
Here we propose a laboratory protocol that uses 
standard laboratory instrumentation firstly, to screen 
samples for potential NPS and then to purify and confirm 
the identity of the potential NPS.  To demonstrate the 
protocol six herbal products were purchased from UK- 
based web sites and  screened for the presence of synthetic 
cannabinoids using a fast GC-MS method; a modification 
of a method previously developed in our laboratory 
for the analysis of novel psychoactive substances (Elie 
et  al., 2012). The method successfully separates a range 
of synthetic cannabinoids that are tentatively identified 
by mass spectral comparison with the SWGDRUG mass 
spectral library. As a proof of principle the synthetic 
cannabinoid AM-2201 was selected for purification using 
an analytical HPLC system in a preparative mode. The 
purity of AM 2201 was confirmed by HPLC-DAD and its 
chemical structure confirmed using NMR.
2  Materials and methods
2.1  Samples
Six herbal products were purchased from UK-based web 
sites (Table 1). Samples 1 and 5 had the same brand name 
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(Pineapple express) and the same packaging but were 
purchased from different retailers and with a 5 month 
difference in purchase date. Samples 3 and 6 had the 
same name (Doob) but were purchased from different 
retailers and with different packaging. The product name 
of sample 4 (UR-144) suggested the active principle from 
the sample was UR-144. Sample 2 was obtained prior to 
the generic control of synthetic cannabinoids in the UK in 
December 2009.
2.2  Preparation of sample extracts
The full content of each package was homogenised using 
a previously reported  technique using medium grade (100 
grit) sand paper (Logan et al. 2012). Homogenization was 
done by rubbing the herbal material between two pieces 
of sand paper (10 x 10cm each). A piece of sand paper was 
used in the later GC-MS analysis as a negative control.
100 mg of ground herbal material was extracted 
using 1ml of methanol (HPLC grade, Fischer Scientific, 
UK), followed by vortexing for 5 minutes and sonication 
for 10 minutes. The extracts were filtered through 0.45µm 
syringe filters (Chromacol) into vials and frozen at -20 oC 
until use.
All the analyses were carried out using the methanolic 
extracts, except for the NMR analysis.
2.3  Analytical Conditions
Analytical and preparative HPLC analyses were done 
using Merck Hitachi HPLC system with C18 column 
(Eclipse Plus C18, 4.6 x 250mm, 5µm, Agilent) and 
diode array detector L-7455. The mobile phase used was 
methanol:water (70:30), and the analytes were separated 
under isocratic conditions. The mobile phase flow was 
1 ml/min, and the oven temperature was 40°C. The scan 
range of the diode array detector (DAD) was 200-400 nm. 
In the analytical mode, the injection volume of the 
extracts was 10µl and the run time 45 minutes, while for 
the isolation of the substance (preparative mode) 40 µl of 
sample 6 extract was repeatedly injected using a column 
overload procedure.
The extracts of the 6 samples were screened using a 
fast GC-MS method (Elie et al, 2013) modified for synthetic 
cannabinoid analysis. Analysis was carried out using a 
Perkin Elmer Clarus 600 gas chromatograph with column 
SLB™-5ms fused silica capillary column (10m x 0.1mm 
x 0.1µm film thickness) (Supelco analytical). The gas 
chromatograph was coupled with Perkin Elmer Clarus 
600C mass spectrometer, equipped with Perkin Elmer 
TurboMass software (2008). 
The initial conditions for the  gas chromatograph and 
the mass spectrometer were set according to data from 
the literature for the conventional GC-MS methods for 
synthetic cannabinoids (Zuba et al. 2011) and the method 
for screening for other legal highs currently used in the 
laboratory (Elie et al., 2012), since no methods have been 
optimized for synthetic cannabinoids using fast GC-MS. 
The oven programme was initial temperature 240°C, then 
ramp to 290°C at rate 50°C/min, ending with a plateau 
for 6 minutes (total run time 7 minutes). Mass spectra 
were searched against NIST and SWGDRUG libraries 
NIST compatible, in demo version of NIST MS search 2.0 
programme. 
The 1H NMR analysis of the isolated substance 
was performed in Cardiff School of Pharmacy and 
Pharmaceutical Sciences, Cardiff University. The 
instrument used was multi nuclear gradient Bruker 
Avance 500 MHz. The solvent used for the NMR analysis 
was deuterium labelled chloroform (CDCl3) (supplier).
2.4  Determination of the HPLC retention 
time of the target substance 
The eluent corresponding to each HPLC peak of a 20 µl 
injection of Sample 6 extract was collected as a separate 
fraction using a simple manual procedure. This was 
carried out in triplicate and the fractions for each peak 
were pooled and evaporated to dryness under a gentle 
stream of nitrogen, reconstituted in 75 µl methanol and 
analysed by the fast GC-MS method. 
2.5  Isolation of the target substance
A total volume of 640 µl of sample 6 extract (16 x 40 µl 
injections) was injected and the fraction containing the 
target substance was collected. The 16 separate fractions 
were pooled and the mobile phase was evaporated under 
a stream of nitrogen. When almost fully evaporated the 
solution was transferred to a 1.5 ml eppendorf tube and 
evaporated to dryness. 0.5 mg of the isolated substance 
was dissolved in methanol and analysed by HPLC as a 
purity check. Ratios of the isolated substance’s peak area 
and total peak area of the chromatogram were used to 
calculate purity of the substance. 2.7 mg of the isolated 
substance was analysed by NMR.
3  Results and Discussion
Fast GC-MS analysis, using MS comparison with the 
SWGDRUG mass spectral library, suggested the presence 
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of four synthetic cannabinoids in the purchased samples 
(Table 1). Fast GC-MS of methanolic extracts provides 
a simple and effective tool that we have applied in our 
laboratory for screening large numbers of drug samples in 
NPS casework. When coupled with the SWGDRUG library 
and NIST software it provides a tentative identification 
even when specific drugs may not have been previously 
analysed in our laboratory. The fast GC-MS screening 
method was initially developed for detection of 
amphetamine/cathinone based NPS (Elie et al, 2012). 
A number of the more recently available synthetic 
cannabinoid NPS do not elute under these conditions 
and so the GC programme was modified to run at higher 
temperatures with a longer runtime when synthetic 
cannabinoids are suspected in the sample such as in the 
analysis of herbal NPS products. This still provides a fast 
screening method as shown by the retention times of all 
the identified synthetic cannabinoids in table 1 being less 
than 4 minutes.
As a proof of principle one of the Doob samples (sample 
6) was selected for purification of the NPS component by 
HPLC. The peak at 3.85 minutes in the chromatogram of 
Sample 6 (figure 1) was identified as AM-2201, a synthetic 
cannabinoid first synthesized by Alexandros Makriyannis 
(Makriyannis et al, 2007). 
Analytical HPLC of sample 6 extract showed six peaks 
in the chromatogram (figure 2). Each peak of the extract 
was isolated, collected and analysed by the fast GC-MS 
method. This identified the HPLC peak with retention 
time 16.67 minutes as being the substance identified as 
AM-2201. The other peaks could not be matched against 
the SWGDRUG database in agreement with the fast GC-MS 
analysis of the methanol extract (figure 1).
This substance was subsequently isolated from 640 µl 
of sample 6 extract using a column overload preparative 
mode of HPLC using the same analytical column. A 
total mass of 3.2 mg of the substance was isolated using 
a total volume of 1667 ml methanol and a total run time 
of 2035 minutes that included blank runs between each 
extract run. From the mass of AM-2201 recovered and the 
volume of extract analysed, the calculated concentration 
in sample 6 was 5.2% (52 mg/g product) assuming that the 
recovery was 100%. 
The HPLC chromatogram (figure 3) confirms the purity 
of the isolated substance and provides an estimate of purity 
of 97.5% calculated using the ratio of the peak area at 16.67 
minutes to the total area under the chromatogram. The DAD 
UV spectrum (figure 3) is also shown with main absorption 
bands at 220 and 315 nm which is in agreement with the 
spectrum previously reported (Denooz et al, 2013).
The remaining isolated substance was analysed by 
both 1H and 13C NMR. The spectral data are presented in 
table 2 and both proton and carbon assignments are in 
agreement with the molecular formula of C24H22NOF and 
with the data presented by Denooz et al confirming the 
substance as AM-2201. This agreement also confirms the 
structure as the 1-naphthyl isomer and not the 2-naphthyl 
isomer. AM-2201 is an example of one of the group of 
second generation synthetic cannabinoids that appeared 
on the legal high market following the UK generic control 
of synthetic cannabinoids in 2009. It belongs to the 
class known as naphthoylindoles and circumvents the 
2009 generic control by having a fluoro-substituent on 
the alkyl side-chain. In early 2013 AM-2201 was one of a 
number of second generation synthetic cannabinoids to 
be controlled in the UK.    
Application of a column overload method by injecting 
an increased volume of the sample, as a preparative 
HPLC method, means that smaller amount of the 
isolated substance can be obtained and the time for the 
isolation will be longer as compared to the application 
of a preparative column. However, this approach can be 
used in more laboratories since preparative columns are 
not part of routine analytical equipment. Obtained UV 
spectra can be used as additional information about the 
substance analysed and help with the identification if 
there are spectral libraries available.
4  Conclusions
With the frequency at which new synthetic cannabinoid 
receptor agonists appear on the legal highs market, 
it is difficult for analytical laboratories to have all 
possible reference materials needed for the unequivocal 
identification of the present drugs. In the absence of 
reference materials isolation of the analysed substance 
from the mixture is an alternative approach since the 
NMR analysis of the isolated and purified substance can 
provide the definitive identification. Several milligrams 
of the substance are sufficient for NMR analysis and 
with isolation of larger amounts it can be used as an 
in-house purified reference material for further analyses. 
The isolation approach using a column overload method 
with analytical HPLC column is suitable for use in most 
analytical laboratories.  
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Figure 1: (a) Fast GC-MS chromatogram of the sample 6 extract and (b) EI mass spectrum of the peak at 3.85 minutes. The mass spectra of 
AM-2201 and its 2’ naphthyl isomer taken from the SWGDRUG 2013 MS library are also shown as spectra (c) and (d) respectively.  
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Figure 3: HPLC chromatogram of the isolated substance with its Diode Array Detector UV spectrum (insert).
Figure 2: Sample 6 extract HPLC chromatogram with the six peaks that were isolated and ran on the fast GC-MS to determine the retention 
time of the peak containing AM-2201.
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Table 2:  1H   and 13C NMR spectral data of the isolated substance (AM-2201), recorded at 500 MHz in CDCl3. Chemical shifts (δ) and multipli-
cities are presented in the table, except  for the aromatic hydrogens in positions 4, 5, 6, 7’, 8’, 11’ and 12’, the signals of which could not be 
fully resolved. Comparison is made with the data of Denooz et al. 
Position 1H* (δ [ppm], multiplicities**, 
the number of hydrogens)
Denooz et al 13C Denooz et al
1 - - - -
1’ 4.10 (t, 2H) 4.28 (t, 2H) 47.81 46.17 (CH2)
2’ 1.90 (m, 2H) 1.84 (m, 2H) 30.49 28.99 (CH2)
3’ 1.45 (m, 2H) 1.28 (m, 2H) 23.60 21.90 (CH2)
4’a 1.65 (m, 1H) 1.58 (m, 1H) 30.88 29.13 (CH2)
4’b 1.75 (m, 1H) 1.61 (m, 1H) 31.04 29.28 (CH2)
5’a 4.35 (t, 1H) 4.31 (t, 1H) 83.94 82.93 (CH2)
5’b 4.45 (t, 1H) 4.41 (t, 1H) 85.25 84.22 (CH2)
2 7.70 (s, 1H) 7.79 (s, 1H) 141.01 139.36 (CH)
3 - - 118.30 116.08 (C)
3a - - 138.75 136.79 (C)
4 7.50-7.60** 7.64(m, 1H) 111.70 111.03 (CH)
5 7.35-7.40* 7.33 (m, 1H) 124.87 123.30 (CH)
6 7.35-7.40* 7.33 (m,1H) 124.01 122.46 (CH)
7 8.50 (d, 1H) 8.32 (d, 1H) 123.39 121.71 (CH)
7a - - 128.21 126.38 (C)
8 - - 194.73 190.86 (C)
6’ - - 140.19 139.36 (C)
7’ 7.50-7.60** 7.65 (m, 1H) 126.55 125.70 (CH)
8’ 7.50-7.60** 7.64 (m, 1H) 125.84 124.96 (CH)
9’ 8.20 (d, 1H) 8.09 (d, 1H) 131.20 129.68 (CH)
9’a - - 135.29 133.31 (C)
10’ 8.00 (d, 1H) 8.03 (d, 1H) 129.45 128.27 (CH)
11’ 7.35-7.40* 7.56 (t, 1H) 127.44 126.26 (CH)
12’ 7.35-7.40* 7.51 (t, 1H) 127.85 126.70 (CH)
13’ 7.95 (d, 1H) 8.01 (t, 1H) 126.98 125.27 (CH)
13a’ - - 132.03 130.06 (C)
* a group of 4H not fully resolved; ** a group of 3H not fully resolved
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